Tizanidine extended release - Sun Pharma

Drug Profile

Tizanidine extended release - Sun Pharma

Alternative Names: SPARC 1401; Tizanidine ER

Latest Information Update: 13 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sun Pharma Advanced Research Company
  • Class Antispastics; Benzothiazoles; Imidazolines; Muscle relaxants; Small molecules
  • Mechanism of Action Alpha 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Musculoskeletal pain

Most Recent Events

  • 13 Oct 2016 Sun Pharma Advanced Research Company completes a phase-II trial in Musculoskeletal pain (In volunteers) in Netherlands (EudraCT2015-003770-32) prior to October 2016
  • 20 Sep 2016 Sun Pharma Advanced Research Company plans a phase II trial for Back pain in USA (NCT02887534)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top